Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Oncol., 07 November 2025

Sec. Cancer Epidemiology and Prevention

Volume 15 - 2025 | https://doi.org/10.3389/fonc.2025.1705495

Correction: PFOA biomonitoring and kidney cancer risk: a meta-analysis of serum levels

  • 1Department of Drug Science and Technology, University of Turin, Turin, Italy
  • 2Department of Medical Sciences, University of Turin, Turin, Italy
  • 3Molecular Biotechnology Center, University of Turin, Turin, Italy
  • 4Department of R&D, Aspidia srl, Milan, Italy
  • 5Institute for Biomedical Technologies, National Research Council, Segrate, Italy

A Correction on
PFOA biomonitoring and kidney cancer risk: a meta-analysis of serum levels

By Spyrakis F, Tiburtini GA, Bruno S, Dragani TA and Colombo F (2025). Front. Oncol. 15:1593300. doi: 10.3389/fonc.2025.1593300

There was a mistake in Figures 2 and 3, as well as Supplementary Figures 2 and 4 as published. In the original version of the article, we mistakenly used the beta coefficient for the association between log-PFOA and kidney cancer from Steenland et al., 2022, instead of its OR value.

Figure 2
Figure 2 contains two forest plots from random-effects meta-analyses of studies on serum or plasma PFOA concentrations and renal cancer risk. Panel A shows relative risks and 95% confidence intervals per natural log-unit increase in PFOA levels. Panel B compares the upper versus lower quartile of PFOA concentrations, using upper quintile data for one study. Each plot displays study-specific estimates with confidence intervals, a pooled summary diamond, and the Higgins & Thompson’s I² statistic indicating heterogeneity.

Figure 2. Forest plot (random-effects model) of studies’ relative risks, 95% confidence intervals (CI), and meta-analyses for: (A) Per natural log-unit increase in serum/plasma PFOA concentrations (ng/mL) and renal cancer risk. (B) Upper versus lower quartile in serum/plasma PFOA concentrations and renal cancer risk. *, Upper quintile data was used, as quartiles were not available in Steenland et al. I², Higgins & Thompson’s statistic.

Figure 3
Funnel plots labeled A and B display risk ratios against standard error. Plot A shows data points with a risk ratio range of 0.9 to 1.3, while plot B ranges from 1.0 to 2.5. Both plots feature symmetrical dotted lines forming an inverted funnel shape.

Figure 3. Funnel plot of Egger’s test on the associations between PFOA exposure and risk of renal cancer among studies included in the meta-analysis. (A) Overall serum/plasma PFOA concentrations (ng/mL) and renal cancer risk. (B) Upper versus lower quartile in serum/plasma PFOA concentrations and renal cancer risk.

The corrected Figures 2 and 3 appear below. The correct Supplementary Figures 2 and 4, have now been replaced.

In the Abstract, “0.59 (95% CI: 0.06–5.89)” was wrong.

This has been corrected to read:

“1.05 (95% CI: 0.69–1.60)”

In the Abstract, 0.98 (95% CI: 0.64–1.50) was wrong.

This has been corrected to read:

“1.36 (95% CI: 0.35–5.23)”

“0.59 (95% CI: 0.06–5.89)” was an error.

“(I² = 90%, P < 0.01)” was an error.

A correction has been made to the section Results, paragraph 3:

“1.05 (95% CI: 0.69–1.60)”

“(I2 = 77.4%, P = 0.012)”

“0.98 (95% CI: 0.64–1.50)” was an error.

“with no statistically significant heterogeneity among the studies (I² = 0%, i = 0.66).” was an error.

A correction has been made to the section Results, paragraph 3:

“1.36 (95% CI: 0.35–5.23)”

“with statistically significant heterogeneity among the studies (I2 = 77.0%, P = 0.013)”

“(P = 0.30 and P = 0.81, respectively)” was an error.

A correction has been made to the section Results, paragraph 3:

“(P = 0.49 and P = 0.30, respectively)”

“0.59 (95% CI: 0.06–5.76)” was an error.

“(I² = 89%, P < 0.0001)” was an error.

A correction has been made to the section Results, paragraph 5:

“1.05 (95% CI: 0.68–1.60)”

“(I2 = 77.5%, P = 0.012)”

“0.96 (95% CI: 0.64–1.45)” was an error.

“with no statistically significant heterogeneity among the studies (I² = 0%, P = 0.71).” was an error.

“(P = 0.37 and P = 0.58, respectively)” was an error.

A correction has been made to the section Results, paragraph 5:

“1.37 (95% CI: 0.35–5.35)”

“with statistically significant heterogeneity among the studies (I² = 76.9%, P = 0.013).”

“(P = 0.55, both)”

“0.75 (95% CI: 0.04–16.01)” was an error.

“with a significant heterogeneity among the studies (I² = 91%, P < 0.01).” was an error.

“(P = 0.74)” was an error.

A correction has been made to the section Results, paragraph 6:

“1.19 (95% CI: 0.92–1.53)”

“with no significant heterogeneity among the studies (I² = 20.8%, P = 0.28).”

“(P = 0.66)”

The original version of this article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: biomonitoring, kidney, PFAS, PFOA, renal cancer

Citation: Spyrakis F, Tiburtini GA, Bruno S, Dragani TA and Colombo F (2025) Correction: PFOA biomonitoring and kidney cancer risk: a meta-analysis of serum levels. Front. Oncol. 15:1705495. doi: 10.3389/fonc.2025.1705495

Received: 15 September 2025; Accepted: 06 October 2025;
Published: 07 November 2025.

Edited and reviewed by:

Francesca Coperchini, University of Pavia, Italy

Copyright © 2025 Spyrakis, Tiburtini, Bruno, Dragani and Colombo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Tommaso A. Dragani, dG9tLmRyYWdhbmlAYXNwaWRpYS5jb20=

ORCID: Francesca Spyrakis, orcid.org/0000-0002-4016-227X
Gioele Antonio Tiburtini, orcid.org/0009-0003-2989-4343
Stefania Bruno, orcid.org/0000-0002-8879-9536
Tommaso A. Dragani, orcid.org/0000-0001-5915-4598
Francesca Colombo, orcid.org/0000-0003-2015-4317

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.